ClinicalTrials.gg
TerminatedNCT03324828SONRISAUpdated Aug 11, 2020

Presurgery Anxiolysis in Children Treated With Hydroxyzine Versus Non-pharmacological Intervention (Distractoria Technique Clown)

A Phase 4 interventional study of Hydroxyzine and Clowns intervention in Anxiety, sponsored by Hospital San Carlos, Madrid. Terminated at 1 site in Spain. Open to participants aged 2 Years to 16 Years. Per ClinicalTrials.gov, last updated 2020-08-11.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Hospital San Carlos, Madrid · Phase 4, Interventional, and Treatment

Why this study was terminated
COVID-19

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
170
Allocation
Randomized
Ages
2 Years to 16 Years
Sex
All
01

Study summary

This study evaluate the change in preoperative anxiety, baseline (M1) and pre-induction anxiety levels (M3), as shown by children undergoing MAS determined by the m-YPAS scale in the different APO management groups.Patients will be allocated in one of this four groups: hydroxyzine+clown; hydroxyzine alone, clowns alone or nothing

02

Conditions studied

  • Anxiety

Browse trials for

Keywords

  • anxiety
  • surgery
  • clown
03

In context

Anxiety Disorders Unverified

7,207 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's enrollment of 170 is above the median of 80 across 6,062 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Hospital San Carlos, Madrid is the lead sponsor of 74 studies on the registry; 17 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
2 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children between 2 and 16 years old
  • Patients with programmed major ambulatory surgery.
  • Assessment of anesthetic risk .
  • signed by their legal authorized representatives.
  • No antihistaminic allergies.
  • Assent signed by children between 12 and 16 years old.

Exclusion criteria

Exclusion Criteria:

  • Patients with previous surgeries.
  • Anesthetic risk ASA more than II.
  • Patients with to the active substance, to any of the , to cetirizine, to other piperazine derivatives, to aminophylline or etilenamida
  • Patients with porphyria
  • Patients with known , either congenital or acquired
  • Patients with known risk factors for QT prolongation including a pre-existing cardiovascular disease, previous electrolyte imbalances, family history of sudden cardiac death, significant bradycardia and concomitant use of drugs with potential known to produce QT prolongation and / or induce Torsades de Pointes.
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Excipients

The other ingredients in a medicine besides the active drug, such as fillers, colours or preservatives.

QT and QTc

On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.

The study may name a correction formula and a limit in milliseconds, often around 450–480.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
170 participants (actual)

Study arms

  • Active comparator
    Hydroxyzine+no clowns

    Patients will receive hydroxyzine solution and no additional intervention

    Drug: Hydroxyzine

  • Experimental
    Hydroxyzine+clowns

    Patients will receive hydroxyzine solution and clowns intervention

    Drug: Hydroxyzine · Other: Clowns intervention

  • Active comparator
    Placebo+clowns

    Patients will receive placebo solution and clowns intervention

    Other: Clowns intervention

  • No intervention
    Placebo+no clowns

    Patients will receive placebo solution and no additional intervention

Interventions

  • Hydroxyzine solution

  • OtherClowns intervention

    Clowns intervention

06

What researchers measure

Primary outcomes

  1. m-YPAS

    Yale Preoperative Anxiety Scale (mYPAS)

    Time frame: Anxiety in the operation room (average 60 minutes from the begining of the study)

Secondary outcomes

  1. m-YPAS

    Yale Preoperative Anxiety Scale (mYPAS)

    Time frame: Anxiety when the patient arrives at operation room (average 45 minutes from the begining of the study)

  2. Cortisol level (blood)

    cortisol blood test

    Time frame: Just before starting surgery (average 75 minutes from the begining of the study)

  3. Cortisol level (salive)

    cortisol blood test

    Time frame: when the patient arrives at operation room(average 45 minutes from the begining of the study)

  4. Anesthesia induction

    Anesthesia induction according to the checklist

    Time frame: Just before starting surgery (average 75 minutes from the begining of the study)

07

Study locations

1 site
  • Hospital Clinico San Carlos
    Madrid, 28040, Spain
08

References and documents

Publications

  • Aleo E, Picado AL, Abancens BJ, Soto Beauregard C, Tur Salamanca N, Esteban Polonios C, Torrejon MJ, Perrino CG, Rivas A, Arias E, Rodriguez D, Rivas MA, Rojo MLR, Garcia PF, Alarcon JR, San Pedro de Urquiza B. Evaluation of the Effect of Hydroxyzine on Preoperative Anxiety and Anesthetic Adequacy in Children: Double Blind Randomized Clinical Trial. Biomed Res Int. 2021 Nov 11;2021:7394042. doi: 10.1155/2021/7394042. eCollection 2021. PubMed 34805403 ↗
  • Aleo Lujan E, Lopez-Picado A, Rivas A, Joyanes Abancens B, Rodriguez Rojo ML, Fernandez Garcia P, Soto Beauregard C, Rodriguez Alarcon J, Gonzalez Perrino C, San Pedro de Urquiza B, Arias E, Rodriguez D, Esteban Polonio C, Torrejon MJ. Pre-operative anxiolysis in children through a combined pharmacological therapy with hydroxyzine and a non-pharmacological distraction technique with a clown (SONRISA): study protocol for randomised double-blind clinical trial. Trials. 2020 Jan 2;21(1):1. doi: 10.1186/s13063-019-3906-2. PubMed 31898511 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2017 to primary completion in May 2020, 30 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 21, 2017
First posted
Oct 30, 2017
StartActual
Nov 1, 2017
Primary completionActual
May 29, 2020
CompletionActual
May 29, 2020
Last update
Aug 11, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 11, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03324828
Lead sponsor
Hospital San Carlos, Madrid
Responsible party
Esther Aleo Lujan (Esther Aleo Lujan, Principal Investigator, Hospital San Carlos, Madrid) — Principal investigator
First posted
Oct 30, 2017
Start date
Nov 1, 2017
Primary completion
May 29, 2020
Completion
May 29, 2020
Last update
Aug 11, 2020

Study contacts

Esther Aleo Lujan, MD
study chair · Hospital Clinico San Carlos

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Hydroxyzine

Start the discussion